These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23517072)

  • 1. Is haemophilia B less severe than haemophilia A?
    Mannucci PM; Franchini M
    Haemophilia; 2013 Jul; 19(4):499-502. PubMed ID: 23517072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Haemophilia A and haemophilia B. Are there relevant clinical differences?].
    Klamroth R; Orlovic M; Kubicek-Hofman C; Gottstein S
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S26-7. PubMed ID: 21042678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian multicentre study of current real-world prophylaxis practice in severe and moderate haemophilia A and B.
    Mason JA; Parikh S; Tran H; Rowell J; McRae S
    Haemophilia; 2018 Mar; 24(2):253-260. PubMed ID: 29314552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.
    Nagel K; Walker I; Decker K; Chan AK; Pai MK
    Haemophilia; 2011 Nov; 17(6):872-4. PubMed ID: 21342368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Haemophilia A, B or von Willebrand disease type 3. Census of patients in the eastern part of Germany].
    Scholz U; Syrbe G; Koscielny J; Klamroth R;
    Hamostaseologie; 2008; 28(3):150-4. PubMed ID: 18521493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
    Saulyte Trakymiene S; Ingerslev J; Rageliene L
    Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe and moderate haemophilia A and B in US females.
    Di Michele DM; Gibb C; Lefkowitz JM; Ni Q; Gerber LM; Ganguly A
    Haemophilia; 2014 Mar; 20(2):e136-43. PubMed ID: 24533955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.
    Iorio A; Königs C; Reding MT; Rotellini D; Skinner MW; Mancuso ME; Berntorp E
    Haemophilia; 2023 Jan; 29(1):33-44. PubMed ID: 36224704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
    Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
    Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia in Iran.
    Dorgalaleh A; Dadashizadeh G; Bamedi T
    Hematology; 2016 Jun; 21(5):300-10. PubMed ID: 26914731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilia B is clinically less severe than haemophilia A: further evidence.
    Franchini M; Mannucci PM
    Blood Transfus; 2018 Feb; 16(2):121-122. PubMed ID: 27723453
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
    Marijke van den Berg H
    Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders.
    Tagariello G; Iorio A; Santagostino E; Morfini M; Bisson R; Innocenti M; Mancuso ME; Mazzucconi MG; Pasta GL; Radossi P; Rodorigo G; Santoro C; Sartori R; Scaraggi A; Solimeno LP; Mannucci PM;
    Blood; 2009 Jul; 114(4):779-84. PubMed ID: 19357395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.
    Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W;
    Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia a and hemophilia B: different types of diseases?
    Santagostino E; Fasulo MR
    Semin Thromb Hemost; 2013 Oct; 39(7):697-701. PubMed ID: 24014073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Osooli M; Berntorp E; Astermark J
    Haemophilia; 2021 May; 27(3):366-374. PubMed ID: 33780113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients.
    Ghosh K; Shetty S; Kulkarni B
    Haemophilia; 2007 Nov; 13(6):734-9. PubMed ID: 17973850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining severity of hemophilia: more than factor levels.
    Pavlova A; Oldenburg J
    Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis therapy in haemophilia A: current situation in Spain.
    Lucía JF; Aznar JA; Abad-Franch L; Escuin RR; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Alperovich G; Parra R;
    Haemophilia; 2011 Jan; 17(1):75-80. PubMed ID: 21070481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined coagulation factor VIII and factor IX deficiency (CDF8F9) in a patient from Lithuania.
    Ivaškevičius V; Pezeshkpoor B; Biswas A; Goldmann G; Horneff S; Gimbutyte M; Malciute L; Jurgutis R; Oldenburg J
    Hamostaseologie; 2016 Nov; 36(Suppl. 2):S29-S33. PubMed ID: 27824213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.